PCP
CBST

Perimeter Capital Partners’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Perimeter Capital Partners’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,831
Closed -$477K – 188
2014
Q2 		$477K Hold
6,831
– – 0.24% 157
2014
Q1 		$500K Sell
6,831
-101
-1% -$7.53K 0.25% 144
2013
Q4 		$477K Buy
6,932
+2,980
+75% +$193K 0.24% 141
2013
Q3 		$251K Sell
3,952
-81,112
-95% -$4.9M 0.05% 223
2013
Q2 		$4.11M Buy
+85,064
New +$4.18M 0.79% 25

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Perimeter Capital Partners's CBST Position: Q3 2014 in Review

Perimeter Capital Partners sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 6,831 shares — an estimated $477K sold.

Perimeter Capital Partners first reported a position in CBST in Q2 2013 and held it in 5 quarters. The position peaked at $4.11M in Q2 2013. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • Perimeter Capital Partners reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Perimeter Capital Partners sold 6,831 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $477K.
  • Perimeter Capital Partners first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Perimeter Capital Partners's CUBIST PHARMACEUTICALS INC position peaked at $4.11M in Q2 2013.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on Perimeter Capital Partners's 13F filing for Q3 2014, filed 10 Nov 2014.